Kutatási jelek – Signal Engine

• The improbable targeted therapy: KRAS as an emerging target in non‑small cell lung cancer (NSCLC) — NSCLC
• Recent Advances in the Treatment of Pancreatic Cancer — Pancreatic cancer
• Current therapy of KRAS-mutant lung cancer — NSCLC
• Best of 2024 in Prostate Cancer and Prostatic diseases — Prostate cancer
• Comprehensive review of targeted therapy for colorectal cancer — Colorectal cancer
• Treating the TOTAL patient: clinical trial reduces relapse — Acute lymphoblastic leukemia
• Discovery of how colorectal cancer drug works will help more patients — Colorectal cancer
• New pathway for potential glioblastoma treatment — Glioblastoma
• Targeted therapy in advanced thyroid cancer to resensitize tumors to radioactive iodine — Thyroid cancer
• Old cells, new tricks—important clue to AML diagnosis and cure discovered — Acute myeloid leukemia
• A Golden Age of Bladder Cancer Drug Development — Bladder cancer
• Are Doctors Treating More Thyroid Cancer Patients Than Necessary? — Thyroid cancer
• Slowing the Progression of Smoldering Myeloma — Multiple myeloma
• Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study — Leiomyosarcoma
• Melanoma Clinical Trials & Research | Memorial Sloan Kettering Cancer Center — Melanoma
• EBV Screening for the Early Detection of Nasopharyngeal Carcinoma — Nasopharyngeal carcinoma
• Clinical Trials – NCCC — Cervical cancer
• SDH-Deficient Gastrointestinal Stromal Tumor (GIST) — Gastrointestinal stromal tumor
• Trial Failure Still Yields Insights for Uterine Leiomyosarcoma — NSCLC
• AI approach outperformed human experts in identifying cervical precancer — Cervical cancer